- TradedVC
- Posts
- Armada’s $131M Edge‐AI, Trump’s “Woke‐Free” AI Action Plan, & Global VC Roars Back After Q2
Armada’s $131M Edge‐AI, Trump’s “Woke‐Free” AI Action Plan, & Global VC Roars Back After Q2
From heavy-hitter strategic moves to new mega-funds—VC is front-loading for the next-gen winners.

Your dose of daily dealflow, essential VC & tech trends to know. The biggest moves in venture, all in one place. Celebrating startups, founders, and funders.


🧑🍳 Let’s get right into it…
Armada Goes Beast Mode – $131M lands for “Leviathan” AI data centers, built to fuel U.S. energy and AI supremacy (backed by Founders Fund, M12, Lux).
KraneShares Opens the Gates – New VC index fund gives accredited investors a slice of OpenAI, xAI, SpaceX, Stripe, and Anthropic.
U.S. AI Power Play – Trump’s AI Action Plan:
Fast-track data center permits
Ban “woke” AI in federal contracts
Use federal cash to override strict state AI laws
Backed by Nvidia & AMD CEOs.
VC Heats Up Again – Q2 exits hit $67.6B, led by Scale AI’s $14.3B raise (2nd largest ever).
Africa’s Rising Wave – Southern Africa VC up 24% YoY to R13.35B, with Series A taking the crown.

🧠 Dopamine Dealflow
💰 Massive Rounds (€50M+ / $50M+)
5C Group (Berlin, Germany) – $835M equity + debt led by Brookfield and Deutsche Bank to fund AI infrastructure campuses.
Electra (Paris, France) – €433M green loan to accelerate ultra-fast EV charging in Europe.
Zenobē (London, UK) – €325M in financing from MUFG, Siemens, and others to expand EV fleets-as-a-service.
Armada (Miami, FL) – $131M Strategic Round to scale modular AI data centers. Backers include Founders Fund, Lux Capital, and M12.
HeroDevs (Salt Lake City, UT) – $125M Strategic Growth from PSG and Album to secure deprecated open-source software.
Yieldstreet (New York, NY) – $77M led by Tarsadia Investments to scale private markets investment for individual investors.
Gupshup (San Francisco, CA) – $60M+ in equity + debt to expand Conversational AI globally.
LegalOn Technologies (Tokyo, Japan) – $50M Series E led by Goldman Sachs and World Innovation Lab to scale contract review AI.
Seed & Series A ($10M–$30M)
Bitfount (London, UK) – $8M Series A for federated AI research collaboration.
TRIC Robotics (Benton, DE) – $5.5M Seed to deploy UV-light farming robots.
Volca (New York, NY) – $5.5M Seed led by Pathlight Ventures for AI-powered local service marketing.
Queen One (Brooklyn, NY) – $5.5M Friends & Family led by Charge VC and Inspired Capital for brand experience tech.
IdentifAI (Milan, Italy) – €5M to scale deepfake detection.
Reshape Systems (Geneva, Switzerland) – €856K Pre-Seed for industrial AI risk modeling.
Nuuri (Edinburgh, UK) – £275K Pre-Seed for a UK-based nursery search platform.
Strategic & Growth Investments
Bitzero (Fargo, ND) – $25M to expand blockchain & HPC data centers. Investors undisclosed
360Learning (Paris, France) – €1.8M Grant from France’s 2030 fund to advance AI upskilling.
Plexision (Pittsburgh, PA) – $365K Grant from Richard King Mellon Foundation for AI transplant diagnostics.
Modular Devices (Indianapolis, IN) – Strategic growth investment in Transcend Imaging via O2 Investment Partners.
💸 VC Funds Raised & Raising
Blackstone raised ~$5B for its latest infrastructure secondaries fund.
KR Capital (ex‑Marshall Wace PM Ravi Naresh) raised $3B from Millennium for its equity long/short fund.
Optimas Capital Management (Thomas Wong’s Asian L/S fund) raised $1.2B from Millennium.
Great Rock Capital secured a $1.1B senior‑secured leverage facility led by Capital One.
Third Point launched its first dedicated structured private credit fund for insurers, raising $400M.
RA Capital raised $120M for a “Planetary Health” life sciences fund.
Founders: Want to be featured on @tradedvc? → traded.co/submit/vc

📖 Read of the Day
Elon Musk’s brain-tech moonshot is going full throttle:
20,000 chip implants per year planned.
$1B annual revenue projected by 2031 (per Bloomberg).
Telepathy (brain-to-machine), Blindsight (vision restore), Deep (tremor/Parkinson’s treatment) all in the pipeline.
Regulatory approval for Telepathy eyed by 2029, with 2,000 surgeries per year.
By 2030, Blindsight rollout + 10,000 surgeries = $500M+ revenue.
Already valued at $9B, with $650M fresh funding and human trials underway.
Why it matters: Musk’s Neuralink is moving from sci-fi to commercialization, with FDA “breakthrough” tags for both speech and vision restoration.

📰 News You Don’t Want To Miss


@tradedvc posts on 🔥

OVER AND OUT, BACK TO THE GRIND ⚙️
Want more content? We don’t blame you. You can find more TradedVC content on Instagram, LinkedIn, X, and at traded.co/vc✌️